Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2021) 77 P242 | DOI: 10.1530/endoabs.77.P242

1College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; 2Padmashree D.Y. Patil School of Medicine, Navi Mumbai, India; 3Barts Health NHS Trust, London, United Kingdom; 4The Dudley Group NHS Foundation Trust, Dudley, United Kingdom; 5King Edward VI High School for Girls, Birmingham, United Kingdom; 6PCOS Vitality, Bristol, United Kingdom; 7PCOS Verity, London, United Kingdom; 8PCOS Club India, New Delhi, India; 9Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom; 10Birmingham Women’s Hospital, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom; 11Apollo Hospitals, Navi Mumbai, India; 12Department of Endocrinology, MS Ramaiah Medical College, Bengaluru, India; 13Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom


Aim: To study differences in various aspects of emotional wellbeing among women with PCOS living in the UK and India.

Methods: Women with PCOS were invited to complete an online survey between September and October 2020 in the UK and May and June 2021 in India. The survey included Hospital Anxiety and Depression Scale (HADS; score ≥11 cases of anxiety and depression, respectively), Body Image Concern Inventory (BICI; score ≥72 suggestive of body dysmorphic disorder, BDD), Beliefs About Obese Persons Scale (BAOP; higher score suggestive of weight bias) and Female Sexual Function Index (FSFI; higher score suggestive of psychosexual dysfunction). The Mann-Whitney U test was used to make comparisons between women from both countries.

Results: A total of 758 women, living in the UK (n = 344) and India (n = 414) completed the survey. The prevalence of anxiety and depression were 62.1% overall, with higher prevalence in Indian women (56.4% UK vs 66.9% India; P = 0.003) and 25.6% (20.6% UK vs 29.7% India, P = 0.001). Overall, 36.5% had BDD with a significantly higher prevalence in the UK women (47.7% UK vs 27.3% India; P = 0.000). UK women had higher scores for BAOP compared to Indian women (overall: 30/48 (25.0-35.0); UK: 32.0 (27.0-35.0) vs India: 29.0 (23.0-34.0); P = 0.000). A similar trend was seen for psychosexual dysfunction (overall scores for FSFI: 21.0/36 (8.4-26.5); UK: 23.30 (10.75-28.00); vs India: 19.85 (7.83-25.5); P = 0.000).

Conclusion: A differential impact on emotional wellbeing with PCOS in the two countries suggest other factors such as socioeconomic status, deprivation and education which may play a role. Future studies are needed to explore this further.

Volume 77

Society for Endocrinology BES 2021

Edinburgh, United Kingdom
08 Nov 2021 - 10 Nov 2021

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.